10x Genomics

10x Genomics

TXG· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +13.6% in FY2025

Serge Saxonov is the CEO of 10x Genomics and was paid $6.3M in FY2025 (Dec), down 20%.

Pay$100 in the stock at the end of FY20 → $12
CEO pay is from each 10x Genomics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Serge SaxonovFY2025
  2. 2Eric S. WhitakerFY2025
  3. 3Benjamin J. HindsonFY2025
  4. 4Adam S. TaichFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

10x Genomics paid its 4 named executives $14.6M in total in FY2025 (Dec). CEO Serge Saxonov was paid $6.3M of that.

Name
Serge SaxonovChief Executive Officer
Eric S. WhitakerFormer Chief Legal Officer
Benjamin J. HindsonPresident and Chief Scientific Officer
Adam S. TaichChief Financial OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers19

See all

The FY2025 (Dec) proxy of 10x Genomics names 19 peer companies for pay. Among 10x Genomics and these peers, CEO pay was 6th highest of 8 and total shareholder return was the lowest of 8.

6th highest of 8in 10x Genomics and its pay peers, FY2025 (Dec) by CEO pay:

$851.6K$18.9M

8th highest of 8in 10x Genomics and its pay peers, FY2025 (Dec) by total shareholder return:

$12$230

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • Benjamin J. HindsonDirector · 13 yr on the boardNot independent—Paid as an executive
  • Sri KosarajuDirector · 6 yr on the boardIndependentMergers and Acquisitions (Chair)—Paid as an executive
  • Kimberly J. PopovitsDirector · 5 yr on the boardIndependentAudit, Compensation—Paid as an executive
  • Alan V. MateoDirector · 1 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. Pay
    10x Genomics CEO pay fell 20% to $6.3M. The stock rose 14% in FY2025 (Dec).
    DEF 14A
  2. Pay
    10x Genomics General counsel pay fell 51% to $3.4M. The stock rose 14% in FY2025 (Dec).
    DEF 14A
  3. Pay
    10x Genomics President pay fell 39% to $2.6M. The stock rose 14% in FY2025 (Dec).
    DEF 14A
  4. Pay
    10x Genomics CFO pay fell 32% to $2.2M. The stock rose 14% in FY2025 (Dec).
    DEF 14A
  5. Pay
    10x Genomics General counsel pay rose 80% to $7.0M. The stock fell 74% in FY2024 (Dec).
    DEF 14A
  6. Board
    Alan V. Mateo joined the board of 10x Genomics. Alan V. Mateo sits on no other public board.
    3
  7. Pay
    10x Genomics CEO pay fell 56% to $8.3M. The stock rose 54% in FY2023 (Dec).
    DEF 14A
  8. Pay
    10x Genomics CEO pay rose 61% to $18.8M. The stock fell 76% in FY2022 (Dec).
    DEF 14A
  9. Pay
    10x Genomics Former CFO pay fell 52% to $3.3M. The stock rose 54% in FY2023 (Dec).
    DEF 14A
  10. Pay
    10x Genomics Former CFO pay rose 53% to $6.8M. The stock fell 76% in FY2022 (Dec).
    DEF 14A
  11. Pay
    10x Genomics Former Chief Commercial Officer pay fell 78% to $1.9M. The stock rose 54% in FY2023 (Dec).
    DEF 14A
  12. Pay
    10x Genomics General counsel pay fell 67% to $3.9M. The stock rose 54% in FY2023 (Dec).
    DEF 14A
  13. Pay
    10x Genomics General counsel pay rose 117% to $11.9M. The stock fell 76% in FY2022 (Dec).
    DEF 14A
  14. Pay
    10x Genomics President pay fell 55% to $4.4M. The stock rose 54% in FY2023 (Dec).
    DEF 14A
  15. Pay
    10x Genomics President pay rose 80% to $9.9M. The stock fell 76% in FY2022 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 24, 2026FY2025
Annual report10-KFeb 13, 2026FY2025
Proxy statementDEF 14AApr 14, 2025FY2024
Annual report10-KFeb 13, 2025FY2024
Proxy statementDEF 14AApr 26, 2024FY2023
Annual report10-KFeb 15, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data